Risk factor
Negligible price volatility
Profitability factor
Excellent dividends
In Guru Portfolios
About
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. The company was founded in 1973 and is headquartered in Paris, France.
Company Valuation
Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA, underpriced
Target Price
The average target price of SNY is 54.1 and suggests 14.9% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation